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Abstract
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Folate receptor is a membrane bound protein which is highly expressed by cancer cells
and macrophages. Folic acid is required for the normal growth of cells and it has been found that
rapidly growing cancer cells require high levels of folic acid. Folic acid binds to folate receptors
and through receptor mediated transport folate enters cells. This property has been used to
synthesize a probe using folate as ligand through polyethylene glycol-Biotin linker. This can be
used to attach a drug which is ultimately delivered at the site of infectious cells. The study
involved here was to determine how folate and magnetic beads can be used to develop imaging
systems and transport drugs to identify and treat pathologies. Folate-PEG-Biotin probe (already
synthesized from Dr. Walter Henne and Mr. Rohan Patel) was purified by HPLC and LC/MS
which was then used to perform cell binding studies with streptavidin coated magnetic beads on
L1210 type cancer cells. Biotin which is a B-complex vitamin is also required for the growth of
cells. This biotin has the highest non-covalent affinity to streptavidin in nature and hence was
used to link streptavidin coated magnetic beads to folate. Polyethylene glycol was used as a
spacer. This streptavidin protein in the form of magnetic beads captures cells from solution when
used with the Folate-PEG-Biotin probe. Cells were observed under a high resolution light
microscope and the images were taken with a high resolution camera available from Dr. Tim
Gsell’s laboratory. Cells were also studied by just adding streptavidin beads alone to observe if
they were captured. To another control, Folate-PEG-Biotin/Streptavidin coated magnetic beads
were added along with 1000 fold excess of folic acid.
This method is economical and can be used to replace other cancer cell detection techniques.
Future studies include the conjugation of folate-peg-biotin probe with a proprietary drug
conjugate to determine the drugs activity on cancer cells which will be carried out at Purdue
University.
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Introduction
Folic Acid: Folic acid (Figure 1) is vitamin B9, and naturally occurs as folate. Folic acid
shows its activity in the form of its tetrahydrofolate derivative9. Folic acid is required for the
synthesis of DNA and its repair. It is also required as a cofactor in some biological reactions. It is
required in the body for cell division and growth of cells. Lack of folic acid in the body leads to
anemia as folate is required for the synthesis of red blood cells. Recent studies provide evidence
that high levels of folic acid assist in growth of some cancer cells. It has been found that cancer
cells require folate in order to divide and maintain its functions.
Folate Receptor: Folate receptor alpha (Figure 3) is a glycophophatidylinositol (GPI)
membrane bound protein which is encoded by the FOLR1 gene1. These kinds of proteins have a
high affinity towards folic acid and its derivatives and aid in receptor-mediated transport of folic
acid into the cancer cells. It has been found that tumors of epithelial origin express high FRalpha levels than normal cells2-3. FR- α receptors are prominently observed in cancers of kidney,
ovary, lung, colon, lung, brain etc4. Studies have shown the presence of folate receptors on many
different cancerous tissues5-6. This enabled researchers to identify the potential of folate
receptors in targeted drug delivery and diagnosis methods7-8.

Streptavidin: It is a protein of the tetramer10-11 kind obtained from Streptomyces avidinii.
It has the high non-covalent binding towards biotin11. Its resistance towards organic solvents,
enzymes, high temperature and pH proves useful for research studies12.
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Here, we used streptavidin coated magnetic beads to isolate cancer cells13. Magnetic
beads are made of iron. Magnetic property of the beads pulls the constructed ligand from the
solution and also the cells when introduced.
Biotin: It is a B-complex vitamin which is required for cell growth. Biotin is generally
used to isolate proteins by linking it to proteins, a process called biotinylation14. Biotin has high
affinity and binds specifically to a protein named streptavidin15. This affinity between biotin and
streptavidin has been used to isolate cancer cells through folate-PEG-biotin.
Polyethylene Glycol (PEG): It is a polymer of ethylene oxide and in this study, it has
been used as a spacer between streptavidin and biotin that reduces aggregation by decreasing
steric hindrance and increases solubility and also reduces toxic and immunological effects.
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Materials
a) MagnabindTM Streptavidin from Thermo Scientific: Capacity- 2µg Biotin/ml resin
Lot no: KH1223234
Prod # 21344
b) Biotin-PEG Resin- from Novabiochem
c) Cancer Cells- L1210 from Purdue University.
d) RPMI Medium 1640 from Gibco/Invitrogen
[+]L-Glutamine
[+]Phenol Red
[-]Folic acid
Reference no: 27016-021
Lot no: 714204
e) Phosphated Buffered Saline, 1X from Cellgro (Mediatech, Inc)
Without Calcium and Magnesium
Cat. No. 21-040-CV
Lot. No. 21040174
Exp-

07/2011
8

Method
Preparative HPLC of Folate-PEG-Biotin
The synthesized sample was then purified on a HPLC from Hewlett Packard, series 1050
equipped with a Diode array detector.
The following method and parameters were adopted:
Column: Rigel C18
Solvent A: Ammonium Bicarbonate Buffer
Solvent B: Acetonitrile
Flow Rate: 1ml/min
Run Time: 60 min.

No.

Time

%B

(min)
1

0

1

2

5

1

3

35

30

4

45

50

5

55

60

6

60

1
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LC/MS Analysis
Sample from the HPLC run was collected. This sample was then analyzed with LC/MS to
confirm the identity and purity of the sample through its mass spectra under negative ion mode.
Column: Eclipse XDB C18
Solvent for Negative Ion Mode: Methanol and Water.
Sample Size: 30µl
Flow Rate: 0.5ml
Run Time: 10 min
Scan Range: 600-1000 m/z.

Time in min

Methanol(%)

0

30

1

50

2

70

3

90
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Capture of FR-α Cells With Streptavidin Coated Magnetic Beads
To 1ml cancer cells, 10µl of purified Folate-PEG-Biotin sample was added. This was
stirred for 15 minutes at 37degrees (angle) on a mechanical shaker. The sample was then
centrifuged for a minute. Upon centrifugation, unbound cells separated out at the top and were
removed with a pipette. To the obtained sample 500µl of PBS was added. This mixture was
shaken for 15 minutes and then centrifuged for a minute. Clear liquid that separates out at the top
is removed. This wash with PBS was repeated twice. To the washed sample, 500µl of PBS and
50µl of streptavidin coated magnetic beads were added. It was then stirred for 15 minutes and
allowed to stand for 3 minutes on a magnetic stand. Any unbound cells were pipetted out. The
resulting sample was then washed with PBS, stirred for 15 minutes and centrifuged twice to
remove any unbound cells.
Another 1 ml of the same cancer cell type was taken as control. To this, streptavidin
coated magnetic beads alone were added. To another control, Folate-PEG-Biotin and streptavidin
coated magnetic beads were added along with 1000-fold excess of folic acid.
Both the controls and cells under study for capture were observed under a high resolution
light microscope.
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Results and Discussion
The chromatogram described in figure 4 is that of Folate-PEG-Biotin. The large intense
peak at 37 minutes was proved by the DAD spectrum (figure 5) which shows maximum
absorbance at 284 and 350nm. Minor peaks adjacent to the main peak are due to some impurities
present in the sample. To confirm Folate-PEG-Biotin identity, the sample was collected and
subjected to LC/MS analysis.
A Purified sample from preparative run from HPLC was collected and analyzed in
LC/MS. Figure 6 shows an intense peak at 5.2 minutes for LC-DAD. The peak (molecular ion
peak) at m/z 868 (figure 7) for the negative ion mode matches the calculated value of 869 for
Folate-PEG-Biotin. This confirms the identity of the purified sample. Peaks at m/z 891 may be
due to sodium adducts present in glassware or instruments.
Cells under study were then observed under a light microscope and images were captured
with a camera. Images obtained confirm that only streptavidin (coated onto magnetic beads)
conjugated to Folate-PEG-Biotin could capture cells. Cells that were added with streptavidin
alone (control) could not penetrate the cell membrane. For control-2, excess of folic acid is taken
up by the cancer cells and hence streptavidin coated magnetic beads could not capture the cancer
cells.
Conclusion
Folate can be used as a ligand for isolation and detection of cells. In this work we were
able to use magnetic beads to isolate FR+ cancer cells. Since cancer cells express high folate
receptors and required large amount of folate for metabolism, folate can be used to transport
drugs into cells by developing folate based ligands for imaging and therapeutic purposes. This
12

way, folate can be used as a ligand to selectively deliver chemotherapeutic agents. This ensures
that only impaired cells will have the effects of the drug and normal cells would be left
untouched. This property of folate can be utilized to develop many more therapeutics agents for
the cure of various cell related abnormalities and diseases.
Magnetic beads can be used to isolate cells through linkage to ligands for isolating cells.
We could easily visualize the cells coated with beads. Thus, we were able to capture and detect
with the same system. This magnetic property can be used for future studies for developing
photo-magnetic imaging systems. It is a simple process and economical. This may be combined
with other down-stream applications besides microscopy such as flow cytometry to count cells
captured.
Future Studies
Further study may involve how folate can be used as a ligand to develop imaging and
therapeutic agents and delivering drugs specifically at the target. Folate receptor targeted therapy
is just not limited to cancer but also to large number of diseases. This is mainly because of its
high expression in tumors and macrophages. Advantages like low cost, ease of handling,
suitability for use with various agents, “lack of immunogenicity and specificity to pathologic
cells” makes it a useful agent in studying and developing folate based imaging systems and
constructing chemotherapeutic agents with ligands for therapeutic purposes.
Funding
Funds and equipment were made available by Dr. Walt Henne and Governors State
University throughout the completion of the project.
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Figure 9: Cells Isolated by Folate-PEG-Biotin/Streptavidin Coated Magnetic Beads
a)

Streptavidin Coated
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